Novetide Overview
- Founded
- 1999
- Status
- Private
- Latest Deal Type
- Joint Venture
- Financing Rounds
- 1
Novetide General Information
Description
Provider of peptide synthesis technology research and production processes. The company's peptide synthesis technology research and production processes is engaged in research and development, production and marketing of complex generic and innovative peptides, enabling pharmaceutical industry to avail tailor-made and cost effective management processes for their project.
Contact Information
Website
www.novetide.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Primary Office
- POB 10140
- Haifa Bay 26111
- Israel
+972 00-000-0000
Novetide Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Novetide‘s full profile, request access.
Request a free trialNovetide Patents
Novetide Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10889620-B2 | Solid state forms of linaclotide | Active | 01-Jul-2015 | 00000000 | 0 |
| EP-3317292-A2 | Solid state forms of linaclotide | Pending | 01-Jul-2015 | 00000000 | |
| US-20190194256-A1 | Solid state forms of linaclotide | Granted | 01-Jul-2015 | 00000000 | |
| US-20180057558-A1 | Synthesis of glp-1 peptides | Abandoned | 23-Sep-2014 | 0000000000 | |
| EP-3221342-A1 | Synthesis of glp-1 peptides | Withdrawn | 23-Sep-2014 | C07K14/605 |
Novetide Executive Team (3)
Novetide Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Novetide‘s full profile, request access.
Request a free trial